Last reviewed · How we verify
NCT03765749
Empirical Antibiotic and Outcome in Community-onset Bacteremia
trial in Bacteremia in 108 participants. Completed in 31 December 2021.
31 December 2021
Quick facts
| Lead sponsor | Phramongkutklao College of Medicine and Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 108 |
| Start date | 22 November 2018 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Thailand |
Conditions studied
- Bacteremia — all drugs for Bacteremia →
Sponsor
Phramongkutklao College of Medicine and Hospital
Who can join
18 and older, any sex, with Bacteremia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Empirical antibiotic and outcome in Community-onset Bacteremia Caused by third generation cephalosporin resistant Enterobacteriaceae
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of Inappropriate Empirical Antibiotic on Outcomes in Community-acquired Third Generation Cephalosporin Resistant <i>Enterobacterales</i> Bacteremia.
Nasomsong W, Changpradub D, Vasikasin V. · · 2022 · cited 3× · PMID 36596682 · DOI 10.3947/ic.2022.0096
Verify or expand the search:
- PubMed search for NCT03765749
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bacteremia
Currently open trials in the same condition.
- NCT07134751 — Febrile Infants Swedish Study · recruiting
- NCT07126106 — Prospective Validation of GRADY: A Machine Learning Model for Early Sepsis and Bacteremia Detection in ICU Patients · recruiting
- NCT06821282 — Surveillance of AMR in DRC · recruiting
- NCT06425367 — Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients with Ente · NA · recruiting
- NCT07486362 — Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge · recruiting
Other Phramongkutklao College of Medicine and Hospital trials
Trials by the same sponsor.
- NCT07366450 — High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma · NA · not yet recruiting
- NCT07014371 — Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA) · NA · recruiting
- NCT06491342 — Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease · NA · completed
- NCT06279507 — Efficacy of Hyaluronic Acid Injection in Knee Osteoarthritis · Phase 4 · unknown
- NCT06049771 — The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carba · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03765749 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Phramongkutklao College of Medicine and Hospital
- Last refreshed: 19 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03765749.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing